Market Trends of Asia-Pacific Insulin Syringe Industry
Rising diabetes prevalence
Diabetes is associated with many health complications. Patients with diabetes require many corrections throughout the day for maintaining normal blood glucose levels, such as oral anti-diabetic medication, insulin administration, or the ingestion of additional carbohydrates by monitoring their blood glucose levels.
Furthermore, patients attempting to control their blood glucose levels tightly to prevent the long-term complications associated with fluctuations in blood glucose levels are at greater risk for overcorrection and the resultant hypoglycemia. Achieving nominal results can be very difficult without multiple daily injections of insulin or insulin pump therapy.
Moreover, the increasing adoption of insulin-delivery devices and the rising prevalence of diabetes are driving market growth. Leading manufacturers are focusing on technological innovations and the development of advanced products to gain a substantial share of the market.
Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period.
India is expected to dominate the Asia-Pacific Insulin Syringe Market over the forecast period
Nearly 10% of India's population is likely to be affected by diabetes over the forecast period. Obesity, especially central obesity, increased visceral fat due to physical inactivity, and consumption of high-calorie, high-fat, and high-sugar diets are the major contributing factors to diabetes in Indians. The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in India.
Authorities and healthcare institutions in India are placing a growing emphasis on the significance of managing and preventing diabetes. Efforts to increase awareness about diabetes, encourage healthy lifestyle decisions, and guarantee access to crucial diabetes care supplies such as insulin syringes are being rolled out in different regions. Furthermore, continuous enhancements in healthcare facilities and availability are bolstering the expansion of the insulin syringe market in the nation.
According to the Ministry of Health and Family Welfare of the Government of India, in 2022, out of all deaths in India, 60% were related to non-communicable diseases like diabetes, cardiovascular diseases, cancer, chronic respiratory diseases, etc. To prevent and control major NCDs, the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) has been launched. This program includes medical education, health awareness in schools, and urban planning for diabetes.
Such factors have contributed to the rise in the adoption of these products in the Indian market.
